WallStreetZenWallStreetZen

NASDAQ: CVKD
Cadrenal Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Cadrenal Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CVKD annual revenue was $0.0, with N/A growth year-over-year.

CVKD revenue history

Current Revenue
$0.0
Current Earnings
-$10.7M
Current Profit Margin
0%

Be the first to know when CVKD announces revenue.

CVKD Revenue History By Year

CVKD Yearly RevenueCVKD RevenueCVKD ChangeCVKD Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A

1 of 1

Cadrenal Therapeutics Revenue FAQ

What was CVKD's revenue last quarter?

Cadrenal Therapeutics (NASDAQ: CVKD) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Cadrenal Therapeutics's revenue was $0.00.

What was Cadrenal Therapeutics's revenue in 2024?

Cadrenal Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Cadrenal Therapeutics make in a day?

Based on Cadrenal Therapeutics annual revenue for the past two years, CVKD makes an average of $0.00 per day.

What was Cadrenal Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Cadrenal Therapeutics's revenue has grown null year over year. Cadrenal Therapeutics's revenue in the past year totaled $0.00.

How much does Cadrenal Therapeutics make in a year?

Cadrenal Therapeutics's revenue by year for the past two years is:
  • Cadrenal Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Cadrenal Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.